Intranasal Insulin Reduces White Matter Hyperintensity Progression in Association with Improvements in Cognition and CSF Biomarker Profiles in Mild Cognitive Impairment and Alzheimer’s Disease

BACKGROUND: Intranasally administered insulin has shown promise in both rodent and human studies in Alzheimer’s disease; however, both effects and mechanisms require elucidation. OBJECTIVE: We assessed the effects of intranasally administered insulin on white matter health and its association with c...

Descripción completa

Detalles Bibliográficos
Autores principales: Kellar, D., Lockhart, S.N., Aisen, P., Raman, R., Rissman, R.A., Brewer, J., Craft, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233712/
https://www.ncbi.nlm.nih.gov/pubmed/34101779
http://dx.doi.org/10.14283/jpad.2021.14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233712/
https://www.ncbi.nlm.nih.gov/pubmed/34101779
http://dx.doi.org/10.14283/jpad.2021.14

Ejemplares similares